Extracellular vesicles regulate metastable phenotypes of lymphangioleiomyomatosis cells via shuttling ATP synthesis to pseudopodia and activation of integrin adhesion complexes
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Extracellular vesicles (EVs) promote lung metastasis in pulmonary lymphangioleiomyomatosis (LAM) by enhancing cell migration and invasion. This research identifies novel EV-dependent mechanisms and establishes the LAM pathway as a therapeutic target.
Area Of Science
- Oncology
- Cell Biology
- Pulmonary Medicine
Background
- Pulmonary lymphangioleiomyomatosis (LAM) is a rare, metastatic cancer.
- Mechanisms driving LAM metastasis are poorly understood.
- The role of extracellular vesicles (EVs) in LAM has not been investigated.
Purpose Of The Study
- To investigate the role of extracellular vesicles (EVs) in LAM metastasis.
- To identify molecular mechanisms by which EVs contribute to LAM progression.
- To explore the therapeutic potential of targeting EV-dependent pathways in LAM.
Main Methods
- Analysis of EV biogenesis and cargo in LAM patient samples.
- In vitro studies assessing the impact of LAM-EVs on LAM cell migration and invasion.
- Investigation of signaling pathways (e.g., ITGα6/β1-c-Src-FAK-AKT axis) involved in EV-mediated effects.
- In vivo mouse models to evaluate the effect of LAM-EVs on lung metastatic burden.
- Analysis of extracellular matrix remodeling in response to LAM-EVs.
Main Results
- EV biogenesis is increased in LAM.
- LAM-EVs are enriched with lung-tropic integrins, metalloproteinases, and cancer stem cell markers.
- LAM-EVs enhance LAM cell migration and invasion via the ITGα6/β1-c-Src-FAK-AKT axis.
- EVs regulate metastable phenotypes crucial for metastasis.
- LAM-EVs increase lung metastatic burden and extracellular matrix remodeling in vivo.
Conclusions
- Extracellular vesicles play a significant role in promoting LAM lung metastasis.
- Novel EV-dependent mechanisms regulate tumor cell metastable phenotypes.
- Targeting the LAM pathway presents a promising therapeutic strategy for LAM.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...